1. An economic evaluation of the randomized controlled trial of topical corticosteroid and home‐based narrowband ultraviolet B for active and limited vitiligo (the HI‐Light Vitiligo Trial). (4th November 2020) Authors: Sach, T.H.; Thomas, K.S.; Batchelor, J.M.; Perways, A.; Chalmers, J.R.; Haines, R.H.; Meakin, G.D.; Duley, L.; Ravenscroft, J.C.; Rogers, A.; Santer, M.; Tan, W.; White, J.; Whitton, M.E.; Williams, H.C.; Cheung, S.T.; Hamad, H.; Wright, A.; Ingram, J.R.; Levell, N. Journal: British journal of dermatology Issue: Volume 184:Number 5(2021) Page Start: 840 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Randomized controlled trial of topical corticosteroid and home‐based narrowband ultraviolet B for active and limited vitiligo: results of the HI‐Light Vitiligo Trial. (28th December 2020) Authors: Thomas, K.S.; Batchelor, J.M.; Akram, P.; Chalmers, J.R.; Haines, R.H.; Meakin, G.D.; Duley, L.; Ravenscroft, J.C.; Rogers, A.; Sach, T.H.; Santer, M.; Tan, W.; White, J.; Whitton, M.E.; Williams, H.C.; Cheung, S.T.; Hamad, H.; Wright, A.; Ingram, J.R.; Levell, N.J. Journal: British journal of dermatology Issue: Volume 184:Number 5(2021) Page Start: 828 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗